Authors:
TAKAMURA N
SHINOZAWA S
MARUYAMA T
SUENAGA A
OTAGIRI M
Citation: N. Takamura et al., EFFECTS OF FATTY-ACIDS ON SERUM BINDING BETWEEN FUROSEMIDE AND VALPROIC ACID, Biological & pharmaceutical bulletin, 21(2), 1998, pp. 174-176
Authors:
NARAZAKI R
WATANABE H
MARUYAMA T
SUENAGA A
OTAGIRI M
Citation: R. Narazaki et al., AN IMMUNOLOGICAL METHOD FOR THE DETECTION OF CAPTOPRIL-PROTEIN CONJUGATE, Archives of toxicology, 72(4), 1998, pp. 203-206
Authors:
MOMOEDA M
TSUTSUMI O
MORITA Y
IGARASHI T
SUENAGA A
OSUGA Y
SHIOTSU H
YANO T
TAKETANI Y
Citation: M. Momoeda et al., DIFFERENTIAL EFFECT OF EXOGENOUS HUMAN CHORIONIC-GONADOTROPIN ON PROGESTERONE PRODUCTION FROM NORMAL OR MALFUNCTIONING CORPUS-LUTEUM, Human reproduction (Oxford. Print), 13(7), 1998, pp. 1907-1911
Authors:
TAKAMURA N
MARUYAMA T
AHMED S
SUENAGA A
OTAGIRI M
Citation: N. Takamura et al., INTERACTIONS OF ALDOSTERONE ANTAGONIST DIURETICS WITH HUMAN SERUM-PROTEINS, Pharmaceutical research, 14(4), 1997, pp. 522-526
Authors:
SHIRABE S
NAKAMURA T
TSUJINO A
NISHIURA Y
FURUYA T
GOTO H
SUENAGA A
NAKANE S
YOSHIMURA T
NAGATAKI S
Citation: S. Shirabe et al., SUCCESSFUL APPLICATION OF PENTOXIFYLLINE IN THE TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY, Journal of the neurological sciences, 151(1), 1997, pp. 97-101
Authors:
TAKAHASHI Y
MIYAJIMA H
SHIRABE S
NAGATAKI S
SUENAGA A
GITLIN JD
Citation: Y. Takahashi et al., CHARACTERIZATION OF A NONSENSE MUTATION IN THE CERULOPLASMIN GENE RESULTING IN DIABETES AND NEURODEGENERATIVE DISEASE, Human molecular genetics, 5(1), 1996, pp. 81-84
Authors:
TAKAMURA N
HARUTA A
KODAMA H
TSURUOKA M
YAMASAKI K
SUENAGA A
OTAGIRI M
Citation: N. Takamura et al., MODE OF INTERACTION OF LOOP DIURETICS WITH HUMAN SERUM-ALBUMIN AND CHARACTERIZATION OF BINDING-SITE, Pharmaceutical research, 13(7), 1996, pp. 1015-1019
Authors:
SUENAGA A
SHIRABE S
NAKAMURA T
MOTOMURA M
TSUJIHATA M
MATSUO H
KATAOKA Y
NIWA M
ITOH M
NAKATAKI S
Citation: A. Suenaga et al., SPECIFICITY OF AUTOANTIBODIES REACT WITH OMEGA-CONOTOXIN MVIIC-SENSITIVE CALCIUM-CHANNEL IN LAMBERT-EATON MYASTHENIC SYNDROME, Muscle & nerve, 19(9), 1996, pp. 1166-1168
Authors:
SUENAGA A
TACHI C
TOJO H
TANAKA S
TSUTSUMI O
TAKETANI Y
Citation: A. Suenaga et al., QUANTITATIVE-ANALYSIS OF THE SPREADING OF THE MOUSE TROPHOBLAST IN-VITRO - A MODEL FOR EARLY INVASION, Placenta, 17(8), 1996, pp. 583-590
Authors:
TAKAMORI M
TAKAHASHI M
YASUKAWA Y
IWASA K
NEMOTO Y
SUENAGA A
NAGATAKI S
NAKAMURA T
Citation: M. Takamori et al., ANTIBODIES TO RECOMBINANT SYNAPTOTAGMIN AND CALCIUM-CHANNEL SUBTYPES IN LAMBERT-EATON MYASTHENIC SYNDROME, Journal of the neurological sciences, 133(1-2), 1995, pp. 95-101
Authors:
MATSUI M
ENOKI M
MATSUI Y
OONO S
OHTA M
SUENAGA A
KURODA Y
Citation: M. Matsui et al., SERONEGATIVE MYASTHENIA-GRAVIS ASSOCIATED WITH ATONIC URINARY-BLADDERAND ACCOMMODATIVE INSUFFICIENCY, Journal of the neurological sciences, 133(1-2), 1995, pp. 197-199
Authors:
OHTSURU I
MATSUO H
FUKUDOME T
SUENAGA A
TSUJIHATA M
NAGATAKI S
Citation: I. Ohtsuru et al., SPLIT TOLERANCE INDUCTION BY INTRATHYMIC INJECTION OF ACETYLCHOLINE-RECEPTOR IN A RAT MODEL OF AUTOIMMUNE MYASTHENIA-GRAVIS - IMPLICATIONS FOR THE DESIGN OF SPECIFIC IMMUNOTHERAPIES, Clinical and experimental immunology, 102(3), 1995, pp. 462-467